Device
Conventional extracorporeal circulation
Conventional extracorporeal circulation is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed267%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
Inflammatory Response and Oxidative Stress in Cardiac Surgery: Min. Invasive vs. Conventional Extracorporeal Circulation
NCT06477757
completednot_applicable
Miniaturized Extracorporeal Circulation Study
NCT03216720
completednot_applicable
Platelet Function in Minimal Extracorporeal Circulation in CABG
NCT01935245
Clinical Trials (3)
Showing 3 of 3 trials
NCT06477757Not Applicable
Inflammatory Response and Oxidative Stress in Cardiac Surgery: Min. Invasive vs. Conventional Extracorporeal Circulation
NCT03216720Not Applicable
Miniaturized Extracorporeal Circulation Study
NCT01935245Not Applicable
Platelet Function in Minimal Extracorporeal Circulation in CABG
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3